Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Aligos Therapeutics, Inc. | StockGist | StockGist

Companies
ALGS
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ALGSSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Aligos Therapeutics, Inc.

Filed Aug 12, 2025

Accepted Aug 11, 2025, 8:00 PM ET

CIK 0001799448

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

5,314,801

Reporting Person

Aligos Therapeutics, Inc.

Person Type

IA

CUSIP: 01626L204

Amendment History

4 filings

SCHEDULE 13G
Original
Aug 13, 20250001214659-25-011951
SCHEDULE 13G/A
Amendment 1
Viewing
Aug 12, 20250000902664-25-003496
SCHEDULE 13G/A
Amendment 2
Aug 14, 20250000902664-25-003590
SCHEDULE 13G/A
Amendment 3
Latest
Feb 17, 20260000902664-26-001065

Key Facts

Shares Owned

5,314,801

Recent Filings

Aligos Therapeutics, Inc.1 months ago

Aligos Therapeutics, Inc.1 months ago

Aligos Therapeutics, Inc.1 months ago

Aligos Therapeutics, Inc.1 months ago

Aligos Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice